Glutathione and Chronic Hepatitis B Virus Infection

Year 2021, , 239 - 242, 20.09.2021

Arzu Şenol

https://doi.org/10.54005/geneltip.996762

Abstract

Abstract

Objective: Serum levels of antioxidant glutathione which can be used for diagnosis of liver and liver injury and prevention of chronic liver disease and complications are evaluated.

Material and Methods: The study revealed that patients with hepatitis B virus infection had normal ALT levels, HBV DNA Neg- <104 c / ml 55. 40 control group without any disease and no acute hepatitis were included in the study. Serum GSH levels were determined by ELISA (Enzyme-Linked Immunosorbent Assay) method (R&D Systems, Minneapolis, MN, USA).

Results: Of the hepatitis B virus infected cases, 29 were female and 26 were male (age range 43.75 ± 4.33), 17 of the control group were female and 23 were male (age range 29.31 ± 1.59). Glutathione serum levels in hepatitis B virus infection were lower than control group and this was statistically significant (p: 0.001). There was no statistically significant difference between biochemical parameters and glutathione in patients with hepatitis B virus infection (p> 0.05).

Conculusion: Oxidative stress is important in the development and progression of liver damage Glutathione can be used to diagnose liver inflammation, disease progression. It can also be used to suppress inflammation and prevent the occurrence of chronic liver disease and complications. Broader studies may be useful.

Keywords

Hepatitis B Virus Infection, Glutathione, Oksidatif stres

Hepatit B Virus Enfeksiyonu ve Glutatyon

Abstract

Amaç: Bu çalışmada, hepatit B enfeksiyonlu olgularda, karaciğer enflamasyonunu, hastalık progresyonunu takip etmede tanı için ve karaciğer hasarının ilerleyip, kronik karaciğer hastalığı ve komplikasyonların oluşmasını önlemek için kullanılabilecek antioksidan glutatyonun serum düzeylerine bakıldı.

Gereç ve Yöntem: Çalışmaya kronik hepatit B enfeksiyon’lu, ALT düzeyleri normal, HBV DNA Neg-<104 c/ml 55 olgu ile sağlıklı, herhangi bir kronik hastalığı olmayan ve akut hepatit olmayan, 18 yaş üstü 40 kontrol grubu alındı. ELISA (Enzyme-Linked Immunosorbent Assay) yöntemi (R&D Systems, Minneapolis, MN, USA) ile serum GSH düzeyleri belirlendi.

Bulgular: Hepatit B virus enfeksiyonlu olguların 29’u kadın, 26’sı erkek (yaş aralığı 43.75±4.33), kontrol grubunun 17’si kadın, 23’ü erkek (yaş aralığı 29.31±1.59) idi. Hepatit B virus enfeksiyonunda glutatyon serum düzeyleri kontrol grubundan düşük olup bu istatiksel açıdan anlamlıydı (p: 0.001). Hepatit B virus enfeksiyonlu olgularda, biyokimyasal parametreler ve glutatyon arasında istatiksel olarak anlamlı bir fark saptanmadı ( p>0.05).

Sonuç: Oksidatif stres, karaciğer hasarının gelişimi ve ilerlemesinde önemlidir. Glutatyon, hepatit B enfeksiyonlu olgularda, karaciğer enflamasyonunu, hastalık progresyonunu takip etmede tanı için kullanılabilir. Ayrıca enflamasyonu baskılayarak, kronik karaciğer hastalığı ve komplikasyonların oluşumunu önlemek için kullanılabilir. Daha geniş serili çalışmalar faydalı olabilir.

Keywords

Hepatit B virus enfeksiyonu, Glutatyon, Oxidative stress

References

• Taşbakan MI, Sertöz ÖÖ, Pullukçu H, et al. Comparison of quality of life in hepatitis B virus carriers versus chronic hepatitis B virus carriers versus the normal population. Turk J Med Sci 2010; 40 (4): 575-583.
• Aygen B, Demir AM, Gümüş M, et al. Immunosuppressive therapy and the risk of hepatitis B reactvation. Consensus report. Turk J Gastroenterol 2018; 29:259-69.
• Conde SRS, Feitosa RNM, Freitas FB, et al. Association of cytokine gene polymorphisms and serum concentrations with the outcome of chronic hepatitis B. Cytokin 2013; 61:940–944.
• McMahon BJ. Chronic hepatitis B virus infection. Med Clin North Am 2014; 98:39-54.
• Besharat S, Poustchi H, Mohamadkhani A, et al. Association of Mutationsin the Basal Core Promoter and Pre-core Regions ofthe Hepatitis B Viral Genome and Longitudinal Changesin HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern Iran. Hepat Mon 2015; 15:23875.
• Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology 2007; 39: 44-84.
• Moossavi S, Besharat S, Sharafkhah M, et al. Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron. Middle East Journal of Digestive Diseases 2016; 8(2): 122-130.
• Paracha UZ, Fatima K, Alqahtani M, et al. Oxidative stress and hepatitis C virüs. Virology Journal 2013; 10: 251.
• Qian L, Wang W, Zhou Y, Ma J. Effects of reduced glutathione therapyon chronic hepatitis B. Cent Eur J Immunol 2017; 42 (1): 97-100.
• Dragonjic LP, Jovanovic M, Cvetkovic T, et al. Erythrocyte antioxidative enzymes activities in patients with chronic hepatitis C treated with pegylated interferon alpha-2a and ribavirin. Vojnosanit Pregl 2017; 74(9): 840–848.
• Jones DP, Coates RJ, Flagg EW, et al. Glutathione in foods listed in the National Cancer Institute’s Health Habits and History Food Frequency Questionnaire. Nutrition and Cancer 1992; 17(1): 57-75.
• European Association for the study of the liver (EASL) 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. http://www.easl.eu/medias/cpg/management-of-hepatitis-B-virus-infection/English-report.pdf (accepted date:12.02.2018).
• Yilmaz B, Aydin H, Can G, et al. The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in inactive hepatitis B carriers. European Journal of Gastroenterology & Hepatology 2014; 26: 1325-28.
• Crossan C, Tsochatzis EA, Longworth L, et al. Costeffectiveness of non-invasive methods for assessment and monitoring of liver firosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess 2015; 19: 1-409.
• Guo GH, Tan DM, Zhu PA, et al. Hepatitis B virus X protein promotes proliferation and upregulates TGFbeta1 and CTGF in human hepatic stellate cell line, LX-2. Hepatobiliary Pancreat Dis Int 2009; 8: 59-64.
• Singh RJ. Glutathione: A marker and antioxidant for aging. J Lab Clin Med 2002; 140(6):380-1.
• Pan Z, and Chang C. Gender and the regulation of longevity: Implications for autoimmunity. Autoimmunity Reviews 2012; 11: 393-403.
• Regan JC, and Partridge L. Gender and Longevity: Why do men die earlier than women? Comparative and experimental evidence. Best Practice and Research Clinical Endocrinology and Metabolism 2013; 27: 476- 479.
• Lin C, Liu W, Wang Z, et al. Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection. Eur J Nutr 2011; 50: 499–506.
• Kaya S, Sütçü R, Çetin ES, ve ark. Hepatit B Virusü ile İnfekte Hastalarda Viral Yük ile Lipid Peroksidasyonu ve Antioksidan Enzimler Arasındaki İlişki. Türk Klinik Biyokimya Dergisi 2006; 4(2):77-82.
• Sırmatel F, Duygu F, Çelik H, ve ark. Kronik Viral Hepatit Olgularında Total Oksidatif Seviye ve Total Antioksidan Kapasitenin Değerlendirilmesi. Klimik Dergisi 2009; 22(3): 92-6.
• Ismail NA, Okasha SH, Dhawan A, et al. Glutathione peroxidase, superoxide dismutase and catalase activities in children with chronic hepatitis Advances in Bioscience and Biotechnology 2012; 3: 972-97.
• Czuczejko J, Zachara BA, Topczewska ES, et al. Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases. Acta Biochimica Polonica 2003; 50(4): 1147-1154.
• Şener A, Çevik Ö. Gama-glutamil transferazın oksidatif stres ve kardiyovasküler hastalıklarla ilişkisi. Cumhuriyet Tıp Derg 2013; 35: 291-301.
• Aygün C, Gözel N, Demirel U, ve ark. Kronik Viral Hepatit B Tanısı Olan Hastalarda Serum GGT Düzeyi İle Karaciğer Fibrozu İlişkisi. Fırat Tıp Dergisi 2010; 15(2): 74-78.
• Karlıdağ GE, Ertürk ÜŞ. Kronik Hepatit B Hastalarında Karaciğer Histolojisini Öngörmede Noninvaziv Biyokimyasal Belirteçlerin Değerlendirilmesi. F.Ü. Sağ. Bil. Tıp. Derg 2020; 34 (1): 01-06.
• Amatore D, Matarrese P, Angelis MD, et al. Counteraction of HCV-Induced Oxidative Stress Concurs to Establish Chronic Infection in Liver Cell Cultures. Oxidative Medicine and Cellular Longevity 2019; 10: 1-14.